A low-cost epinephrine autoinjector, the authorized generic for Adrenaclick manufactured by Impax Laboratories, is now available at all CVS Pharmacy locations at a cash price of $109.99 for a two-pack. This compares to a cash price of $649.99 for Mylan’s EpiPen and $339.99 for Mylan’s authorized generic for EpiPen.
CVS “recognized that there was an urgent need in the marketplace for a less-expensive epinephrine autoinjector for patients with life-threatening allergies,” says Helena Foulkes, President of CVS Pharmacy. Over the past year, nearly 150,000 people signed a petition asking for a lower-cost epinephrine autoinjector option and millions more were active in social media searching for a solution.
“In order to address this challenge,” Foulkes adds, “we have partnered with Impax to purchase their epinephrine autoinjector at a price that is lower than similar brand or authorized generic epinephrine autoinjectors.”
The price of $109.99 for the authorized generic Adrenaclick two-pack applies to both insured customers and cash-paying customers without insurance. This solution will be particularly beneficial for insured patients who have consumer-directed health plans and have not yet met their deductible for the plan year. Additional cost reductions for the generic Adrenaclick are available for qualifying patients who use the coupon program offered through Impax, which provides a benefit of $100 per pack.
“We're encouraged to see national efforts to make epinephrine autoinjectors more affordable and more available to Americans across the country,” said Cary Sennett, MD, PhD, President and CEO of the Asthma and Allergy Foundation of America. “Partnerships that increase access to vital medications are key in helping those suffering from life-threatening allergies.”
The authorized generic of Adrenaclick is an FDA-approved device with the same active ingredient as other epinephrine autoinjector devices. The American Academy of Allergy, Asthma, and Immunology includes generic Adrenaclick among therapeutic options in an anaphylaxis emergency action plan.
Source: CVS Health; January 12, 2017.